Anderson Raymond bought MNPR
August 25, 2026 · Form 4 insider transaction
Anderson Raymond bought 1,740 shares of Monopar Therapeutics Inc. at $30.00 per share, a transaction worth $52.2K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,740
Price
$30.00
Total value
$52.2K
InsiderAnderson Raymond
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 25, 2026
Filing dateAugust 28, 2026
Shares owned after8,515
OwnershipDirect
10b5-1 planYes
AmendedYes
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 Plan executed by the reporting person on May 26, 2026.